Stay updated on Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page. No user-visible content changes were observed.
    Difference
    0.0%
    Check dated 2026-03-07T13:06:25.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The site revision tag was updated from v3.4.1 to v3.4.2; there are no changes to study details, eligibility criteria, or results presented on the page.
    Difference
    0.0%
    Check dated 2026-02-13T17:10:47.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page. This appears to be a maintenance/version update without changes to core study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-02-06T11:32:31.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Introduces Show glossary and Hide glossary options and adds labels such as 'Last Update Submitted that Met QC Criteria' with revision text. These changes are mainly UI and metadata tweaks and do not alter core study content.
    Difference
    0.2%
    Check dated 2026-01-23T05:41:30.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision label updated to v3.3.4, replacing the previous v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-16T04:31:54.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing participating sites by state (Alabama, Arkansas, California, Colorado, etc.) and updated the revision to v3.3.3. The previous standalone location blocks and the HHS Vulnerability Disclosure text were replaced.
    Difference
    2%
    Check dated 2025-12-24T23:13:05.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Impact on Vaccine Response in Atopic Dermatitis Clinical Trial page.